Home > Journals > Italian Journal of Dermatology and Venereology > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2019 February;154(1) > Giornale Italiano di Dermatologia e Venereologia 2019 February;154(1):64-71



Publishing options
To subscribe
Submit an article
Recommend to your librarian


Publication history
Cite this article as


REVIEW   Free accessfree

Giornale Italiano di Dermatologia e Venereologia 2019 February;154(1):64-71

DOI: 10.23736/S0392-0488.17.05801-1


language: English

Vitamin D and melanoma: state of the art and possible therapeutic uses

Giovanni PAOLINO 1, Elisa MOLITERNI 1 , Paola CORSETTI 1, Dario DIDONA 2, Ugo BOTTONI 3, Stefano CALVIERI 1, Carlo MATTOZZI 1

1 Clinic of Dermatology, Sapienza University, Rome, Italy; 2 Division of Dermatology, Istituto Dermopatico dell’Immacolata-IRCCS, Rome, Italy; 3 Department of Dermatology, Magna Grecia University, Catanzaro, Italy

Despite the presence of several studies in literature, the real connection between vitamin D serological levels, vitamin D receptor and melanoma remains unclear, probably because of the complex correlation between vitamin D and melanoma. Indeed, UV radiations are not reported as the main risk factor for melanoma in non-sun-exposed, while systemic immunosuppression, anatomical and physiological features may contribute to malignancy. Therefore, the correlation between melanoma cells in sun-exposed areas and vitamin D, as well as vitamin D receptor could be different from the one in melanoma of sun-shielded sites. These differences may also explain the controversial results reported in the literature regarding the correlation between melanoma and vitamin D, as well as the different outcomes in melanoma patients treated with vitamin D as adjuvant therapy. The aim of this review is to highlight the most recent findings about vitamin D and melanoma, focusing on the anatomic site of the primary tumor as well as on the possible therapeutic uses of vitamin D in melanoma patients.

KEY WORDS: Melanoma - Vitamin D - Therapeutics - Neoplasms

top of page